VP7 (31-40) Peptide corresponds to a defined epitope from the VP7 viral protein, containing polar and aromatic residues crucial for recognition. Researchers probe its conformational behavior to map antigenic surfaces. Applications include epitope characterization, peptide-protein binding studies, and structural immunology research.
CAT No: R2828
Synonyms/Alias:VP7 (31-40) peptide; HY-P5667; DA-68632; CS-0888982; 152687-39-3
VP7 (31-40) peptide is a synthetic peptide fragment corresponding to amino acids 31 through 40 of the VP7 protein, a major structural component of the rotavirus outer capsid. As a defined sequence peptide, it serves as a valuable tool for researchers investigating the molecular biology, immunology, and structural features of rotavirus proteins. Its precise sequence enables targeted studies of epitope mapping, antigen-antibody interactions, and protein function, making it highly relevant in virology and vaccine research. The VP7 (31-40) region is of particular interest due to its potential involvement in immune recognition and its contribution to the overall architecture of the viral capsid.
Epitope mapping: The VP7 (31-40) peptide is widely utilized in epitope mapping experiments to identify and characterize antibody binding sites within the VP7 protein. By exposing monoclonal or polyclonal antibodies to this defined sequence, researchers can determine which linear epitopes are recognized by the immune system. These insights are critical for understanding the antigenic landscape of the VP7 protein and for guiding the rational design of immunodiagnostic reagents or subunit vaccine candidates.
Antibody specificity assays: In immunological research, this peptide serves as a reliable standard for assessing the specificity of antibodies generated against rotavirus VP7. By employing the VP7 (31-40) fragment in enzyme-linked immunosorbent assays (ELISA), western blotting, or surface plasmon resonance studies, scientists can distinguish between antibodies that recognize conformational versus linear epitopes. This approach enables the validation of antibody reagents and supports the development of highly selective detection tools for viral proteins.
Structural and functional studies: The defined sequence of the VP7 (31-40) peptide allows for detailed investigations into the structural motifs and functional domains of the VP7 protein. Researchers can use this fragment in binding assays, structural modeling, or nuclear magnetic resonance (NMR) studies to elucidate the conformational properties of the VP7 protein. Such studies contribute to a deeper understanding of how specific regions of the protein participate in capsid assembly, stability, or interactions with host factors.
Peptide-based assay development: The VP7 (31-40) peptide is instrumental in the development and optimization of peptide-based assays for rotavirus research. Its use in competitive binding assays, peptide microarrays, or multiplexed immunoassays enables the sensitive and specific detection of anti-VP7 antibodies in biological samples. These applications are essential for serological surveys, vaccine efficacy studies, and the monitoring of immune responses in experimental systems.
Rotavirus pathogenesis research: By integrating the VP7 (31-40) peptide into experimental models, researchers can probe the role of distinct VP7 regions in rotavirus infection and host-pathogen interactions. The peptide can be used to dissect immune evasion mechanisms, study the modulation of host immune responses, and explore the functional significance of specific capsid segments. This targeted approach advances the understanding of rotavirus biology and supports the identification of novel intervention points for antiviral strategies.
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More